Cohort of Nursing Homes

November 21, 2025 updated by: Institute of Hematology & Blood Diseases Hospital, China

Cohort of Nursing Homes (CNH)

The goal of this observational study was to establish cohorts of elderly people in hospital care and elderly people in home care.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This is an observational study that aims to establish a cohort of elderly people through the nursing homes in the area where the "Tianjin Base" is located, and to scientifically observe and measure the changes and improvements in the health of the elderly population brought about by the new medical care model, such as large-scale elderly care complexes, in order to provide a platform for the study of the health of the elderly population, and thus carry out the exploration of a new model of health promotion. Exploration of new models of health promotion. By comparing the elderly care complex with the home health care mode, and exploring the promotion of "active health" awareness of the elderly through intervention, the investigators will explore the appropriate elderly care mode for different conditions of the elderly population, and explore the advantages of the centralized elderly care mode to be promoted to the home elderly population, so as to establish an elderly care mode that is suitable for the elderly population in Tianjin.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
      • Tianjin, China, 300000
        • Recruiting
        • Institute of Hematology & Blood Diseases Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Elderly people residing in retirement communities with medical facilities and people receiving home care.

Description

Inclusion Criteria:

  • Voluntarily participated in this study and provided signed informed consent forms.
  • Both male and female.
  • Age 60 years old and above.

Exclusion Criteria:

  • Unable to participate in physical examinations due to being bedridden or having limited mobility.
  • Unable to communicate effectively.
  • People cannot participate for other reasons.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Elderly people in medical-nursing care
The elderly people residing in retirement communities with medical facilities
Elderly people in home care
The elderly people receiving home care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health status of elderly people
Time Frame: The diseases status of elderly people will be assessed at baseline and at follow-up visits every 3 to 5 years.
The diseases status of elderly people, including chronic diseases, cancers, and priority diseases.
The diseases status of elderly people will be assessed at baseline and at follow-up visits every 3 to 5 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

August 1, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Actual)

November 25, 2025

Study Record Updates

Last Update Posted (Actual)

November 25, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • QTJC2023072

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Status

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe